Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pulmonology
•
General Pulmonary
•
Obstructive Lung Disease
How do you navigate drug interactions in patients with moderate to severe asthma and HIV on antiretroviral therapy?
Related Questions
Is methacholine challenge on its way out?
What are your top takeaways from ATS 2023?
How long do you normally wait before considering any bronchoscopic procedure (EBUS-TBNA, Transbronchial biopsy) after an episode of acute PE in a patient needing these procedures?
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
Do you prescribe bronchodilators to patients with radiographic emphysema and respiratory symptoms, but no spirometric obstruction?
Can recurrent bilateral nasal polyps be attributed to untreated ABPA?
What is the current recommendation for air travel after a primary spontaneous pneumothorax?
Will you use FeNO testing in all COPD patients to determine whether they are candidates for therapy with dupilumab?
Do you routinely use hypertonic saline for pulmonary toileting in patients with non-CF bronchiectasis?
How do you approach the logistical challenges when using mannitol as an agent for bronchoprovocation testing?
